欢呼尔烟
Lv4
668 积分
2022-09-26 加入
-
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer
2天前
已完结
-
MET Alterations in Cancer and MET-Targeted Therapy: Detection Strategies, Treatment Efficacy, and Emerging Technologies
9天前
已完结
-
691P Efficacy of ABBV-400 monotherapy in patients with MET gene amplified advanced solid tumors
11天前
已完结
-
Results from a phase 1b study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein–overexpressing, EGFR-mutated locally advanced/metastatic non-small cell lung cancer (NSCLC) after progression on prior osimertinib
12天前
已完结
-
ABBV-399, a c-Met Antibody–Drug Conjugate that Targets Both MET–Amplified and c-Met–Overexpressing Tumors, Irrespective of MET Pathway Dependence
12天前
已完结
-
Clinical Relevance of Urokinase-Type Plasminogen Activator, Its Receptor, and Its Inhibitor Type 1 in Endometrial Cancer
22天前
已关闭
-
Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer
23天前
已关闭
-
Relationship of urokinase and urokinase receptor in non-small cell lung cancer to proliferation, angiogenesis, metastasis and patient survival
23天前
已关闭
-
妇科肿瘤免疫检查点抑制剂临床应用指南(2025版)
27天前
已完结
-
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
30天前
已完结